ROS-Responsive Fluorescent Sensor Array for Precise Diagnosis of Cancer via pH-Controlled Multicolor Gold Nanoclusters
ACS Applied Materials & Interfaces · 16.08.2023 · 15 (32) · 38381-38390
DOI: 10.1021/acsami.3c09320 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 02.08.2023. Verfasst von Haifeng Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China. Hauptthemen laut MEDLINE: Neoplasms, Metal Nanoparticles. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Scientific Research Foundation of Education Department of Anhui Province of China, Anhui Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Intracellular reactive oxygen species (ROS) are closely associated with cancer cell types. Therefore, ROS-based pattern recognition is a promising strategy for precise diagnosis of cancer, but such a possibility has never been reported yet. Herein, we proposed an ROS-responsive fluorescent sensor array based on pH-controlled histidine-templated gold nanoclusters (AuNCs@His) to distinguish cancer cell types and their proliferation states. In this strategy, three types of AuNCs@His with diverse fluorescence profiles were first synthesized by only adjusting the pH value. Upon the addition of various ROS, fluorescence quenching of three types of AuNCs@His occurred with different degrees, thereby forming unique optical "fingerprints", which were well-clustered into several separated groups without overlap by principal component analysis (PCA). The sensing mechanism was attributable to the oxidation of AuNCs@His by ROS, as revealed by X-ray photoemission spectroscopy, Fourier transform infrared spectroscopy, 1H nuclear magnetic resonance spectroscopy, and electrospray ionization mass spectrometry. Based on the ROS-responsive sensing pattern, cancer cell types were successfully differentiated via PCA with 100% accuracy. Additionally, the proposed sensor array exhibited excellent performance in distinguishing the proliferation states of cancer cells, which was supported by the results of the Ki-67 immunohistochemistry assay. Overall, the ROS-responsive fluorescent sensor array can serve as a promising tool for precise diagnosis of cancer, indicating great potential for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China.
- Department of Breast Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
ORCID-Profile: Qunlin Zhang
Förderung
- Scientific Research Foundation of Education Department of Anhui Province of China
- Anhui Medical University
- National Natural Science Foundation of China
Zitieren
APA
Lu, H., Lu, Q., Sun, H., Wang, Z., Shi, X., Ding, Y., Ran, X., Pei, J., Pan, Y., & Zhang, Q. (2023). ROS-Responsive Fluorescent Sensor Array for Precise Diagnosis of Cancer via pH-Controlled Multicolor Gold Nanoclusters. ACS Applied Materials & Interfaces, 15(32), 38381-38390. https://doi.org/10.1021/acsami.3c09320
Vancouver
Lu H, Lu Q, Sun H, Wang Z, Shi X, Ding Y, et al. ROS-Responsive Fluorescent Sensor Array for Precise Diagnosis of Cancer via pH-Controlled Multicolor Gold Nanoclusters. ACS Applied Materials & Interfaces. 2023;15(32):38381-38390. doi:10.1021/acsami.3c09320
BibTeX
@article{Lu2023,
author = {Lu, Haifeng and Lu, Qi and Sun, Hongwu and Wang, Zhongkun and Shi, Xiang and Ding, Yuling and Ran, Xiang and Pei, Jing and Pan, Yubo and Zhang, Qunlin},
title = {ROS-Responsive Fluorescent Sensor Array for Precise Diagnosis of Cancer via pH-Controlled Multicolor Gold Nanoclusters},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
volume = {15},
number = {32},
pages = {38381--38390},
doi = {10.1021/acsami.3c09320}
}
EUVIMED